USFDA issues EIR for Lupin Aurangabad facility Ruchika Sharma24 April 2024 11:46 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States...
USFDA successfully concludes inspection at Piramal Pharma USA facility Ruchika Sharma18 April 2024 5:36 PM ISTMumbai: Piramal Pharma Limited has informed through a recent BSE filing that the US Food and Drug ADministration (US FDA) has issued an...
Marksans Pharma gets 5 inspectional observations from USFDA for Goa facility Ruchika Sharma18 April 2024 12:14 PM ISTMumbai: Marksans Pharma has received 5 inspectional observations in Form 483 from the US Food and Drug Administration (USFDA) at...
Granules India gets Zero 483's from USFDA for Unit V facility in AP Ruchika Sharma13 April 2024 12:08 PM ISTTelangana: Granules India has informed in a BSE filing that the Company's Unit V facility located at Anakapally, Visakhapatnam, Andhra ...
USFDA concludes inspection of Lupin Dabhasa facility with no observations Ruchika Sharma13 April 2024 11:48 AM ISTMumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has completed a GMP...
Sun Pharma receives OAI status from USFDA for Dadra facility Ruchika Sharma12 April 2024 11:42 AM ISTMumbai: Sun Pharma has informed in a BSE filing that the US Food and Drug Administration (USFDA) has determined the inspection classification...
Natco Pharma Kothur facility gets USFDA warning letter Ruchika Sharma9 April 2024 2:27 PM ISTHyderabad: Natco Pharma has received a Warning Letter from the United States Food and Drug Administration (USFDA) for its Pharma Division...
Aurobindo Pharma arm gets 3 USFDA observations for AP injectable facility Ruchika Sharma7 April 2024 1:00 PM ISTHyderabad: In a recent BSE filing, Aurobindo Pharma has informed that the new injectable facility of Eugia Steriles Private Limited, a 100%...
Cipla gets 6 USFDA observations for Maha facility Ruchika Sharma5 April 2024 11:51 AM ISTMumbai: Cipla has received six inspectional observations in Form 483 from the United States Food and Drug Administration (USFDA) at the...
USFDA classifies Granules Pharma facility as Voluntary Action Indicated Ruchika Sharma4 April 2024 3:00 PM ISTHyderabad: Granules India has informed in a BSE filing that the United States Food and Drug Administration (USFDA) has classified the facility of...
USFDA inspection: Zydus Lifesciences gets 4 observations for Ahmedabad plant Ruchika Sharma28 March 2024 12:30 PM ISTAhmedabad: Zydus Lifesciences has announced that the Company has received four observations from the U.S. Food and Drug Administration (USFDA) at...
USFDA issues ten observations for Alkem Labs Baddi facility Ruchika Sharma28 March 2024 11:29 AM ISTMumbai: Alkem Labs has announced that the U.S. Food and Drug Administration (USFDA) has issued Form 483 with ten observations at the...
